4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055072
Director sold 2,000 shares at $51.51 ($103,020)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-10-15 | Option exercise | +2,000 | $0.45 | $900 | 2,000 | D: show line 1 in the form |
| HERSHBERG ROBERT Director | 2020-10-15 | Sale | −2,000 | $51.51 | $103,020 | 0 | D: show line 2 in the form |
| Open-market sales · 2,000 sh · avg $51.51 · $103,020 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-10-15 | Option exercise · Stock Option (Right to Buy) | −2,000 | 63,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…